This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08005/identifier/pdb/
n12http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB08005/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08005/identifier/pubchem-substance/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08005/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB08005/identifier/chemspider/

Statements

Subject Item
n2:DB08005
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n12:DB08005 n14:DB08005
dcterms:title
4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide
adms:identifier
n4:17286398 n7:16129582 n8:99444476 n9:DB08005 n10:J07
n5:IUPAC-Name
n6:271B5495-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B549B-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B549A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5497-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5498-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5499-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5493-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5494-363D-11E5-9242-09173F13E4C5 n6:271B5491-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5492-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B54A1-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B54A2-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B549C-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B549D-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B549F-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B549E-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B54A0-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B54A7-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B54A9-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B54AA-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B54A6-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B54A5-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B54A8-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5496-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B54A3-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B54A4-363D-11E5-9242-09173F13E4C5